Real Estate - Development
Compare Stocks
2 / 10Stock Comparison
AXR vs JBSS
Revenue, margins, valuation, and 5-year total return — side by side.
Packaged Foods
AXR vs JBSS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Real Estate - Development | Packaged Foods |
| Market Cap | $142M | $913M |
| Revenue (TTM) | $53M | $1.14B |
| Net Income (TTM) | $13M | $70M |
| Gross Margin | 73.5% | 19.1% |
| Operating Margin | 26.1% | 8.9% |
| Forward P/E | 12.7x | 10.7x |
| Total Debt | $68K | $102M |
| Cash & Equiv. | $40M | $585K |
AXR vs JBSS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| AMREP Corporation (AXR) | 100 | 636.1 | +536.1% |
| John B. Sanfilippo … (JBSS) | 100 | 89.8 | -10.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AXR vs JBSS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AXR is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 1.02
- 5.0% 10Y total return vs JBSS's 101.1%
- Lower volatility, beta 1.02, Low D/E 0.1%, current ratio 28.36x
JBSS carries the broadest edge in this set and is the clearest fit for growth exposure and defensive.
- Rev growth 3.8%, EPS growth -2.3%, 3Y rev CAGR 5.0%
- Beta 0.31, yield 2.7%, current ratio 2.22x
- 3.8% revenue growth vs AXR's -3.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.8% revenue growth vs AXR's -3.3% | |
| Value | Lower P/E (10.7x vs 12.7x) | |
| Quality / Margins | 24.4% margin vs JBSS's 6.2% | |
| Stability / Safety | Beta 0.31 vs AXR's 1.02 | |
| Dividends | 2.7% yield; the other pay no meaningful dividend | |
| Momentum (1Y) | +39.3% vs AXR's +23.8% | |
| Efficiency (ROA) | 11.7% ROA vs AXR's 10.5%, ROIC 15.2% vs 10.2% |
AXR vs JBSS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
AXR vs JBSS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AXR leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JBSS is the larger business by revenue, generating $1.1B annually — 21.6x AXR's $53M. AXR is the more profitable business, keeping 24.4% of every revenue dollar as net income compared to JBSS's 6.2%. On growth, AXR holds the edge at +93.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $53M | $1.1B |
| EBITDAEarnings before interest/tax | $14M | $127M |
| Net IncomeAfter-tax profit | $13M | $70M |
| Free Cash FlowCash after capex | $14M | $33M |
| Gross MarginGross profit ÷ Revenue | +73.5% | +19.1% |
| Operating MarginEBIT ÷ Revenue | +26.1% | +8.9% |
| Net MarginNet income ÷ Revenue | +24.4% | +6.2% |
| FCF MarginFCF ÷ Revenue | +25.7% | +2.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +93.8% | +4.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.5% | +31.9% |
Valuation Metrics
AXR leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 11.3x trailing earnings, AXR trades at a 27% valuation discount to JBSS's 15.5x P/E. On an enterprise value basis, AXR's 8.3x EV/EBITDA is more attractive than JBSS's 8.7x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $142M | $913M |
| Enterprise ValueMkt cap + debt − cash | $102M | $1.0B |
| Trailing P/EPrice ÷ TTM EPS | 11.30x | 15.53x |
| Forward P/EPrice ÷ next-FY EPS est. | 12.69x | 10.68x |
| PEG RatioP/E ÷ EPS growth rate | — | 11.02x |
| EV / EBITDAEnterprise value multiple | 8.32x | 8.73x |
| Price / SalesMarket cap ÷ Revenue | 2.86x | 0.82x |
| Price / BookPrice ÷ Book value/share | 1.11x | 2.54x |
| Price / FCFMarket cap ÷ FCF | 14.71x | — |
Profitability & Efficiency
Evenly matched — AXR and JBSS each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
JBSS delivers a 19.5% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $10 for AXR. AXR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to JBSS's 0.28x. On the Piotroski fundamental quality scale (0–9), AXR scores 5/9 vs JBSS's 2/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +9.6% | +19.5% |
| ROA (TTM)Return on assets | +10.5% | +11.7% |
| ROICReturn on invested capital | +10.2% | +15.2% |
| ROCEReturn on capital employed | +9.8% | +20.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 |
| Debt / EquityFinancial leverage | 0.00x | 0.28x |
| Net DebtTotal debt minus cash | -$40M | $102M |
| Cash & Equiv.Liquid assets | $40M | $585,000 |
| Total DebtShort + long-term debt | $68,000 | $102M |
| Interest CoverageEBIT ÷ Interest expense | — | 26.02x |
Total Returns (Dividends Reinvested)
AXR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AXR five years ago would be worth $24,126 today (with dividends reinvested), compared to $10,395 for JBSS. Over the past 12 months, JBSS leads with a +39.3% total return vs AXR's +23.8%. The 3-year compound annual growth rate (CAGR) favors AXR at 23.9% vs JBSS's -8.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +40.1% | +14.1% |
| 1-Year ReturnPast 12 months | +23.8% | +39.3% |
| 3-Year ReturnCumulative with dividends | +90.3% | -22.9% |
| 5-Year ReturnCumulative with dividends | +141.3% | +4.0% |
| 10-Year ReturnCumulative with dividends | +504.5% | +101.1% |
| CAGR (3Y)Annualised 3-year return | +23.9% | -8.3% |
Risk & Volatility
Evenly matched — AXR and JBSS each lead in 1 of 2 comparable metrics.
Risk & Volatility
JBSS is the less volatile stock with a 0.31 beta — it tends to amplify market swings less than AXR's 1.02 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.02x | 0.31x |
| 52-Week HighHighest price in past year | $29.00 | $85.15 |
| 52-Week LowLowest price in past year | $17.61 | $58.47 |
| % of 52W HighCurrent price vs 52-week peak | +92.3% | +91.7% |
| RSI (14)Momentum oscillator 0–100 | 48.0 | 49.2 |
| Avg Volume (50D)Average daily shares traded | 12K | 80K |
Analyst Outlook
AXR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates AXR as "Buy" and JBSS as "Buy". JBSS is the only dividend payer here at 2.67% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | 1 | 2 |
| Dividend YieldAnnual dividend ÷ price | — | +2.7% |
| Dividend StreakConsecutive years of raises | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $2.08 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% |
AXR leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.
AXR vs JBSS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is AXR or JBSS a better buy right now?
For growth investors, John B.
Sanfilippo & Son, Inc. (JBSS) is the stronger pick with 3. 8% revenue growth year-over-year, versus -3. 3% for AMREP Corporation (AXR). AMREP Corporation (AXR) offers the better valuation at 11. 3x trailing P/E (12. 7x forward), making it the more compelling value choice. Analysts rate AMREP Corporation (AXR) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AXR or JBSS?
On trailing P/E, AMREP Corporation (AXR) is the cheapest at 11.
3x versus John B. Sanfilippo & Son, Inc. at 15. 5x. On forward P/E, John B. Sanfilippo & Son, Inc. is actually cheaper at 10. 7x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — AXR or JBSS?
Over the past 5 years, AMREP Corporation (AXR) delivered a total return of +141.
3%, compared to +4. 0% for John B. Sanfilippo & Son, Inc. (JBSS). Over 10 years, the gap is even starker: AXR returned +504. 5% versus JBSS's +101. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AXR or JBSS?
By beta (market sensitivity over 5 years), John B.
Sanfilippo & Son, Inc. (JBSS) is the lower-risk stock at 0. 31β versus AMREP Corporation's 1. 02β — meaning AXR is approximately 226% more volatile than JBSS relative to the S&P 500. On balance sheet safety, AMREP Corporation (AXR) carries a lower debt/equity ratio of 0% versus 28% for John B. Sanfilippo & Son, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AXR or JBSS?
By revenue growth (latest reported year), John B.
Sanfilippo & Son, Inc. (JBSS) is pulling ahead at 3. 8% versus -3. 3% for AMREP Corporation (AXR). On earnings-per-share growth, the picture is similar: AMREP Corporation grew EPS 89. 6% year-over-year, compared to -2. 3% for John B. Sanfilippo & Son, Inc.. Over a 3-year CAGR, JBSS leads at 5. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AXR or JBSS?
AMREP Corporation (AXR) is the more profitable company, earning 25.
6% net margin versus 5. 3% for John B. Sanfilippo & Son, Inc. — meaning it keeps 25. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AXR leads at 24. 4% versus 7. 7% for JBSS. At the gross margin level — before operating expenses — AXR leads at 66. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AXR or JBSS more undervalued right now?
On forward earnings alone, John B.
Sanfilippo & Son, Inc. (JBSS) trades at 10. 7x forward P/E versus 12. 7x for AMREP Corporation — 2. 0x cheaper on a one-year earnings basis.
08Which pays a better dividend — AXR or JBSS?
In this comparison, JBSS (2.
7% yield) pays a dividend. AXR does not pay a meaningful dividend and should not be held primarily for income.
09Is AXR or JBSS better for a retirement portfolio?
For long-horizon retirement investors, John B.
Sanfilippo & Son, Inc. (JBSS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 31), 2. 7% yield, +101. 1% 10Y return). Both have compounded well over 10 years (JBSS: +101. 1%, AXR: +504. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AXR and JBSS?
These companies operate in different sectors (AXR (Real Estate) and JBSS (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
JBSS pays a dividend while AXR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.